The Journal of Urology
Volume 183, Issue 6 , Pages 2213-2218, June 2010

Positive Surgical Margins at Radical Prostatectomy Predict Prostate Cancer Specific Mortality

  • Jonathan L. Wright

      Affiliations

    • Department of Urology, University of Washington School of Medicine, Seattle, Washington
    • Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington
    • Corresponding Author InformationCorrespondence: Department of Urology, University of Washington Medical Center, Health Sciences Building, 1959 NE Pacific, BB-1115, Box 356510, Seattle, Washington 98195 (telephone: 206-543-3640; FAX: 206-543-3272)
  • ,
  • Bruce L. Dalkin

      Affiliations

    • Department of Urology, University of Washington School of Medicine, Seattle, Washington
  • ,
  • Lawrence D. True

      Affiliations

    • Department of Pathology, University of Washington School of Medicine, Seattle, Washington
  • ,
  • William J. Ellis

      Affiliations

    • Department of Urology, University of Washington School of Medicine, Seattle, Washington
    • Financial interest and/or other relationship with Calypso.
  • ,
  • Janet L. Stanford

      Affiliations

    • Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington
  • ,
  • Paul H. Lange

      Affiliations

    • Department of Urology, University of Washington School of Medicine, Seattle, Washington
  • ,
  • Daniel W. Lin

      Affiliations

    • Department of Urology, University of Washington School of Medicine, Seattle, Washington
    • Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington

Received 20 October 2009 published online 16 April 2010.

Purpose

Positive surgical margins in men undergoing radical prostatectomy for prostate cancer are associated with an increased risk of biochemical recurrence. Few data are available on the role of positive surgical margins in prostate cancer specific mortality. Using a large, population based national cancer registry we evaluated the risk of prostate cancer specific mortality associated with margin status.

Materials and Methods

The SEER cancer registry data for patients diagnosed between 1998 and 2006 were used to identify men undergoing radical prostatectomy for prostate cancer. Margin status, pathological stage, Gleason grade and postoperative radiation therapy were recorded along with demographic data. Multivariate Cox regression analysis was used to estimate the risk of prostate cancer specific mortality associated with positive surgical margins.

Results

A total of 65,633 patients comprised the cohort in which 291 (0.44%) prostate cancer specific deaths occurred during an average followup of 50 months. Positive surgical margins were reported in 21.2% of cases and were more common in pT3a than pT2 tumors (44% vs 18%, p <0.001) and higher grade tumors (28% vs 18%, p <0.001). The 7-year disease specific survival rates for those at highest risk for prostate cancer specific mortality (higher grade pT3a) were 97.6% for cases with negative surgical margins and 92.4% for those with positive surgical margins. Positive surgical margins were associated with a 2.6-fold increased unadjusted risk of prostate cancer specific mortality (HR 2.55, 95% CI 2.02–3.21). Positive surgical margins remained an independent predictor of prostate cancer specific mortality on multivariate analysis (HR 1.70, 95% CI 1.32–2.18).

Conclusions

These data demonstrate the independent role of positive surgical margins in prostate cancer specific mortality. These findings support the importance of optimizing surgical techniques to achieve a sound oncological surgical outcome with negative surgical margins when possible.

Key Words: prostatic neoplasms, survival, population groups, prostatectomy

Abbreviations and Acronyms: BCR, biochemical recurrence, DSS, disease specific survival, NSM, negative surgical margin, PCa, prostate cancer, PCSM, prostate cancer specific mortality, PSA, prostate specific antigen, PSM, positive surgical margin, RP, radical prostatectomy, SEER, Surveillance, Epidemiology and End Results, XRT, radiation therapy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by National Institutes of Health Grant T32 CA009168-30 and the Fred Hutchinson Cancer Research Center.

 See Editorial on page 2126.

PII: S0022-5347(10)00258-2

doi:10.1016/j.juro.2010.02.017

The Journal of Urology
Volume 183, Issue 6 , Pages 2213-2218, June 2010